本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aprea Therapeutics, Inc.

1.59
-0.0150-0.94%
成交量:5.63万
成交额:8.90万
市值:923.30万
市盈率:-0.69
高:1.62
开:1.62
低:1.54
收:1.60
52周最高:5.01
52周最低:1.41
股本:582.53万
流通股本:431.55万
量比:1.35
换手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-2.3101
每股收益(LYR):-2.3519
净资产收益率:-67.54%
总资产收益率:-39.12%
市净率:0.69
市盈率(LYR):-0.67

数据加载中...

2020/05/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/15

重要事件披露

8-K - Current report
2020/04/03

重要事件披露

Current report, item 8.01
2020/03/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/26

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/12/16

重要事件披露

Current report, items 4.01 and 9.01
2019/11/18

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/14

重要事件披露

Current report, items 2.02 and 9.01
2019/11/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

超过5%披露

General statement of acquisition of beneficial ownership
2019/10/17

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

超过5%披露

General statement of acquisition of beneficial ownership
2019/10/11

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/09

超过5%披露

Statement of acquisition of beneficial ownership by individuals